Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,849.82
+0.05%
DAX
26,495.10
+0.39%
CAC 40
8,704.81
-0.12%
STOXX 50
6,563.03
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Thursday 08 July 2021 12:45 pm  |  Updated:  Thursday 08 July 2021 12:46 pm

Covid infection can lead to erectile dysfunction, scientists warn

By: Michiel Willems

Add as a preferred source on Google

The inflammation of blood vessels that typically takes place during a Coronavirus infection may limit the blood flow to the penis, leading to erectile disfunction, scientists have said.

According to Dr Ryan Berglund, a urologist at the Cleveland Clinic in Ohio, warned she has seen a jump in patients with erectile problems only after they had contracted Covid-19.

“The blood vessels that can become inflamed could cause an obstructive phenomenon and negatively impact the ability to get erections,” he told several US media outlets.

“I would suggests young people to get their vaccinations. If they want to have sex better get the vaccine,” Berglund added.

Other vascular diseases, such as coronary artery, high blood pressure and diabetes could also be risk factors for impotency.

Long Covid

Dr. Emmanuele Jannini, professor of endocrinology and medical sexology at the University of Rome Tor Vergata, who has written extensively on the subject, added that erectile dysfunction could be a symptom of ‘long Covid’, he reportedly said.

He warned it could last for months after the initial coronavirus infection. Other common symptoms of ‘long Covid’ are chest pain, heart palpitations, the loss of smell or taste and difficulty breathing.

Los Angeles Times
A California Times publication

Read more

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Health
  • London business

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Hargreaves Lansdown orders staff back to office

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Algoma Central Corporation Reports Financial Results for the 2026 Second Quarter

    Business Wire
  • As it happened: Stocks rise despite new tensions in Strait of Hormuz; Oil price climbs

    FTSE 100 Live
    Bustling shipping activity in the Strait of Hormuz with tankers and cargo ships navigating Iranian waters.
  • Tech, trackers and tourniquets: How England are preparing for Mexico World Cup altitude

    Sport Business
    Getty Images logo on a digital screen, representing a news or business article with visual emphasis on media and photography.
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Promega Achieves 100% Renewable Electricity Across Global Operations

    Business Wire
  • Algoma Central Corporation to Issue Second Quarter Financial Results on August 7, 2026

    Business Wire
  • Liverpool owners tipped to sell – but not to Amazon boss Bezos – by former CEO

    Sport Business
    John W. Henry and Linda Pizzuti Henry with the Premier League trophy at a stadium.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook